Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
Hilary Duff releases 'Mature,' her 1st song in 10 years- Photos: Hundreds Gather at Bondi Beach After Deadly Attack
- Poll: Most are satisfied with their health insurance, but a quarter report denials or delays
- Could it be said that you are As yet Utilizing Old Tires? at These 6 Tire Brands
- Find the Mysteries of Effective Objective Setting: Transforming Dreams into Feasible Targets
- Iran Used $2 Billion in Crypto to Run Its Militant Proxies in 2025
- Computerized Strengthening d: A Survey of \Upgrading Efficiency\ Programming Application
- Advocacy groups react after Mattel introduces 1st Barbie doll with autism
- Dolly Parton misses Dollywood event due to 'a few health challenges' after skipping honorary Oscars
